Skip to main content
Fig. 4 | BMC Nephrology

Fig. 4

From: User of angiotensin-converting-enzyme inhibitor and/or angiotensin II receptor blocker might be associated with vascular calcification in predialysis chronic kidney disease patients: a retrospective single-center observational study

Fig. 4

Time duration association of ACEI/ARB and vascular calcification volume. Patients using ACEI/ARB were categorized into three groups according to the duration time. Thirty-one patients were excluded from the analysis because of unknown duration time. Tukey-Kramer HSD test shows that the longest duration Group 3 has higher log [Calc/BSA] than the shortest Group 1 (p = 0.0060). Jonckheere-Terpstra trend test shows statistically significant increment of log [Calc/BSA] in accordance with the duration time (p = 0.0022). ACEI, angiotensin-converting-enzyme inhibitor; ARB, angiotensin II receptor blocker; BSA, body surface area calculated with Fujimoto’s formula; Calc, calcification volume

Back to article page